Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Curasight to present at Dansk Aktionærforening InvestorDagen

Copenhagen, Denmark, 8 November 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich Krasilnikoff and CMO Andreas Kjær have been invited to present the company’s latest progress and strategy at Dansk Aktionærforening InvestorDagen in Copenhagen 11 November 2024Management will give an overall update on the company’s pipeline based on the proprietary uPAR theranostics platform and focused on diagnosing and treating cancer, and its view on the newly published peer-reviewed data in the journal EJNMMI Research from the Phase II uTRACE trial in

NRC Group ASA – Final result of the Subsequent Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange notice from NRC Group ASA (the "Company") on 24 October 2024 regarding the commencement of the subscription period (the "Subscription Period") in the subsequent offering (the "Subsequent Offering") consisting of up to 20,000,000

Bulletin from the extraordinary general meeting, and the second control meeting, in Qlife Holding AB on 8 November 2024

Today, on 8 November 2024, an extraordinary general meeting, and the second control meeting, was held in Qlife Holding AB. A summary of the adopted resolutions follows below.Resolution on whether the company shall enter into liquidation or continue its operations It was noted that the second control balance sheet shows that the company's total equity is fully restored. On that basis, the extraordinary general meeting resolved in accordance with the primary proposal from the board of directors that the company’s operations shall be continued. Resolution on amendment of the Articles of

LINK Arkitektur wins major school project in Bærum

Multiconsult's (Oslo: MULTI) fully owned subsidiary LINK Arkitektur AS has entered into an agreement with Vedal Entreprenør AS to design a school in Bærum for Akershus County Municipality, Norway.Akershus County Municipality will construct and rehabilitate Rud upper secondary school. The new school will accommodate an increase of approximately 450 student places, bringing the total capacity to 1 300 students. The new building will cover approximately 21 000 m² of space, while the existing building, covering about 1 800 m², will undergo rehabilitation. The project will be carried out as a

Update to Financial Calendar

White Pearl Technology Group AB (WPTG) announces an update to its financial calendar. The Q3 2024 report will be published on Monday, 11 November 2024.Updated Financial Calendar · Q3 2024 Report: 11 November 2024 · Year-end Report 2024: 28 February 2025 (unchanged) All other dates in the financial calendar remain unchanged. For the complete financial calendar, please visit our website at www.whitepearltech.com. For further information, please contact: Investor Relations White Pearl Technology Group AB Email: ir@whitepearltech.com Phone: +46 707 340804 About

Dicot Pharma announces initiation of Phase 2a clinical study

Uppsala, Sweden, November 8, 2024. After recently receiving approval from authorities, the potency drug developer Dicot Pharma's clinical phase 2a study has now started. The primary objective of the study is to evaluate the efficacy of LIB-01 in patients with erectile dysfunction.Recruitment for the phase 2a study began immediately after the authority's approval and is managed by the company's clinical partner CTC, which is conducting the study.  Now the company announces that the study has formally started as the first screening visit has taken place. The primary objective of the phase

Form 8.3 - Anglogold Ashanti Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------------+---------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------------+---------------------+|(b) Owner or controller of interests and short positions|  ||disclosed, if different from 1(a):

COMMUNIQUE FROM THE EXTRAORDINARY GENERAL MEETING 2024-11-08

White Pearl Technology Group AB held its Extraordinary General Meeting today, November 8th. Below is a summary of the material decisions made at the meeting.· The meeting resolved to approve the incentive programmes through the issuance of warrants in two series: · For company executives: 900,000 warrants of series 2024/2027 · For non-employed board directors: 100,000 warrants of series 2024/2027 · The meeting resolved to authorise the board to decide on the issuance of new shares, warrants, and/or convertibles. The authorisation is valid until the next annual general meeting

Shape Robotics invites to presentation of the Q3 2024 Interim Report on 21 November 2024

Herlev, Denmark – 8 November 2024 – Shape Robotics A/S, a leader in educational robotics, hereby invites to a presentation of the company’s business developments and financial results for Q3 2024.The Q3 2024 Interim Report for the period 1 January – 30 September 2024 will be published on 21 November 2024 before the market opening, followed by a video presentation of the results at 10:00 (DK) the same day, available on Shape Robotics’ LinkedIn page  and, subsequently, on the company’s website 

Meatball revolution at sea: 35 tons less meat on Stena Line ships in 2025

By replacing half of the meat in their meatballs with yellow pea mince, Stena Line aims to reduce meat consumption by 35,000 kilos next year. “Taste and quality-wise, it is exactly as good a product as before. But it makes a difference from a sustainability perspective,” says Jakob Lells, Group Executive Chef at Stena Line. A huge change that will hopefully go unnoticed. That’s one way of describing Stena Line’s initiative on 50/50 meatballs, where half of the meat in the popular dish meatballs with mashed potatoes will be replaced next year with a plant-based mince made from

Techstep ASA: Invitation to presentation of Q3 2024 financial results

Techstep ASA will release its third quarter 2024 results on Friday 15 November 2024 at 07:00 CET. The Q3 report and presentation will be made available on the company's website: www.techstep.io , as well as on www.newsweb.no.    At 08:00 CET on the same day, the management will host a presentation and Q&A session where written questions can be submitted to ir@techstep.no or live during the event. The session will be in English. To join, please use this link 

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 241 – 8 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

Correction Interim Report Boho Group January – September 2024

In the previous press release regarding the company's publication of the interim report for the period January - September 2024, there was no reference to the EU Market Abuse Regulation. The title has also been changed to refer to the period January - September 2024.Boho Group AB (publ) today publishes its interim report for the third quarter of 2024. EBITDA improved by 31% JULY - SEPTEMBER 2024 · Revenues from the company's operator business Boho Club amounted to SEK 41,037 thousand (37,331), corresponding to growth of 9.9%. Total revenue from operator business in the third

Stora Enso divests Sunila site to AALTO Development

STORA ENSO OYJ PRESS RELEASE 8 November 2024 at 10:00 EETStora Enso has signed an agreement to divest its real estate of the Sunila site in Kotka, Finland, to AALTO Development Oy. AALTO Development is a Finnish, privately-owned property development company focusing on high-quality architecture and urban planning.Stora Enso will remain in Sunila as a tenant to AALTO Development. The Lignode battery material pilot plant will continue its operations in Sunila. Also, the Sunila-based demonstration plant engineering study, announced earlier by CarbonScape, is unaffected by the transaction.

Invitation to Sensys Gatso’s presentation of the Interim Report for Q3 2024

Sensys Gatso Group, a global leader in traffic safety solutions, publishes the financial report for the third quarter 2024 at 8.30 am CET on Friday November 15 and hereby invites to a presentation/audiocast at 10 am CET. The company’s CEO Ivo Mönnink and CFO Simon Mulder will present the financial results in English.The presentation/audiocast can be joined online or via telephone and will be available on the company’s webpage https://www.sensysgatso.com If you wish to participate via webcast please use the link below.https://ir.financialhearings.com/sensys-gatso-group-q3-report-2024

On November 8, 2024, Nurminen Logistics Plc’s board of directors has decided, with the authorization of the annual general meeting, to pay an equity repayment of EUR 0.04 per share

Nurminen Logistics Plc      Stock Exchange Release November 8, 2024, at 10.00 am On November 8, 2024, Nurminen Logistics Plc's board of directors, with the authorization of the annual general meeting, has decided to pay an equity repayment of EUR 0.04 per share for each of the company's 78,213,164 outstanding shares, i.e. a total of EUR 3,128,526.56. The equity repayment ex-date for the installment shall be November 11[th] 2024, the record date shall be November 12[th] 2024, and the equity repayment date shall be November 19[th] 2024. For the sake of clarity, please note that the capital

Exercise of warrants in Ambea's incentive program 2021/2024

Ambea AB (publ) (“Ambea”) today announces that senior executives and key employees in Ambea have chosen to exercise 291,575 warrants in Ambea's incentive program 2021/2024 for subscription of 291,575 shares in Ambea.   Fifteen senior executives and key employees have chosen to make full use of the opportunity to subscribe for shares in Ambea's long-term incentive program 2021/2024 by exercising warrants. A total of 291,575 warrants have been exercised, each of which entitles the holder to subscribe for one (1) new share in Ambea at a subscription price of SEK 77.90 per share,

Sectra resolves on issue of Class C shares, repurchase of Class C shares and conversion to Class B shares

Linköping, Sweden – November 8, 2024 – The Board of Directors of international medical imaging IT and cybersecurity company Sectra AB  (publ) has resolved, based on the authorization of the Annual General Meeting on September 10, 2024, to issue Class C shares and to subsequently repurchase all of these shares. The Class C shares acquired by the company will be converted to Class B shares. The purpose is to secure the company’s obligations under the share-based long-term incentive program (LTIP 2024) that the Annual General Meeting resolved to implement.The 2024 Annual

QVance AB publishes particulates article in collaboration with ISCT

QVance AB, Huddinge, Sweden has today announced its co-founder and CSO at parent company, NextCell Pharma AB, Dr Lindsay Davies, has published an article in the journal Cytotherapy. Dr Davies is a member of the International Society of Cell and Gene Therapy (ISCT) where she is the European Regional Secretary and a member of the Manufacturing Materials Safety and Technology Working Group (MMST).The article, entitled “Particulates in CGT Guidance Survey Results - Cell and Gene Therapy Industry Knowledge Awareness”, is the result of the MMST´s extensive work to globally survey cell and gene

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 8 November 2024 at 9.45 a.m. (EET) Sitowise Group Plc (the "Company") has on 7 November 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company is above 5.00 percent on 6 November 2024. According to the notification, Morgan Stanley holds indirectly a total of 46,475 shares corresponding to 0,13 percent of the Company’s shares and votes, and a total of 2,456,506

Webstep ASA: Exercise window for share options

Oslo, 8 November 2024: With reference to the stock exchange announcement by Webstep ASA (the “Company”) of 18 November 2019, in which it was announced that Webstep ASA granted employee share options as part of the Company’s long-term incentive programme (“LTIP”).The Company will conduct a window on 14 November - 15 November 2024, in which the option holders may exercise share options. The total amount of vested options is 310,361 options, of which 122,461 options are in the money as of 8 November 2024 and exercisable for the option holders.

Italian leak detection systems manufacturer has become part of Atlas Copco Group

Nacka, Sweden, November 8, 2024: The acquisition of ESA Service S.r.l, (“ESA Service”), a company designing and manufacturing leak detection and gas recovery systems, has been completed and the company has become part of Atlas Copco Group.ESA Service is headquartered at its manufacturing location in Treviglio, Italy. The company has 40 employees and in 2023 revenues amounted to 10.3 MEUR (MSEK 118*). The purchase price is not disclosed. The company has become part of the Scientific Vacuum division within the Vacuum Technique Business Area.

Biosergen publishes interim report for third quarter 2024

Friday November 8, 2024: Biosergen AB (“Biosergen” or the “Company”) hereby publishes the interim report for the third quarter 2024. The interim report is available as an attached document and on the company website (www.biosergen.net)     BIOSERGEN HAS COMPLETED FIRST PATIENT COHORTThe most significant recent result for Biosergen is the successful completion of the treatment of the first cohort of patients in our clinical trial for BSG005. The early data are remarkable, with some patients achieving complete recovery at a low dose of BSG005, while others experienced significant

Moberg Pharma’s Nomination Committee appointed

STOCKHOLM, November 8[th], 2024 – In accordance with the resolution of the Annual General Meeting on May 14[th], 2024, the Chairman of the Board has contacted the company’s two largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee. As not all of the company’s two largest shareholders or group of shareholders have wished to appoint such representative, the third largest shareholder/group of

There are no items matching the current filter
There are no more items matching the current filter
Back to top